The results revealed that the methylation levels of RNASEK in BLCA, HNSC, LIHC, and UCEC tissues were significantly (P < 0.05) lower than those in normal tissues, which may explain the high RNASEK expression in these tumors (Figures 2A-2D). The gene discussed is RNASEK; the disease is bladder transitional cell carcinoma.